The practice of medicine is changing rapidly to include the introduction of automated and algorithmic solutions to clinical and operational challenges.
Watch Now
quotientsciences
Many pharma companies are seeking new ways of making drug development more efficient and cost-effective through innovation, new technologies and process evolution. This has led to an increase in the outsourcing of development activities to contract research partners who focus solely on disciplines such as discovery chemistry, clinical testing, and formulation development and manufacturing.
Watch Now
Business-review-webinars
Current drug development strategies are very expensive and lead to high drug attrition rates. One major reason for low success rates is the lack of predictive preclinical models for efficacy testing. The availability of induced pluripotent stem cell (hiPSC) technologies holds great promise to bring human biology to drug discovery but is still compromised by problems related to scalability, biological relevance, robustness and costs.
Watch Now
Meetings International welcomes you to attend the "Webinar on Pharmaceutical Drug Development and BABE", on February 25, 2022.
Watch Now